Halo Healthcare halohc.com


Public lists: Medical Devices (6162)

Halo Healthcare, formerly NeoMatrix, develops devices that allow women and doctors to promote optimal breast health. The company's premier product, the HALO Breast Pap Test, is a fully automated, non-invasive breast cancer risk assessment device designed for use in the primary care setting as part of an annual well-woman visit. The HALO Breast Pap Test is FDA approved for the collection of nipple aspirate fluid for cytological evaluation. The collected fluid can be used in the determination and/...Show all

Halo Healthcare, formerly NeoMatrix, develops devices that allow women and doctors to promote optimal breast health. The company's premier product, the HALO Breast Pap Test, is a fully automated, non-invasive breast cancer risk assessment device desi...Show all

Company (Alive / Active)

Phone:

Fax:

19800 MacArthur Blvd
Suite 650
Irvine, 92612
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Halo Healthcare $5.2M Jun 25, 2012
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Halo Healthcare Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors

Competitors

Company Status Description Investors

SenoRx

Irvine, California, United States
AcquiredSenoRx develops surgical products for breast cancer.Login to see details

Armune Bioscience

Kalamazoo, Michigan, United States
AcquiredArmune BioScience is a medical diagnostics company that develops and commercializes unique proprietary technology exclusively licensed from the University of Michigan for diagnostic and prognostic tests for prostate, lung and breast cancers.Login to see details
See all 14 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Disposable patient interface for intraductal fluid aspiration system Jul 02, 2015 Application
Method and apparatus for noninvasive intraductal fluid diagnostic screen May 27, 2014 Application